Halozyme Therapeutics Inc. sell The Goldman Sachs Group, Inc.
Start price
04.12.25
/
50%
€53.66
Target price
04.12.26
€48.01
Performance (%)
9.73%
Price
17.04.26
€58.88
Summary
This prediction is currently active. The SELL prediction by The_Goldman_Sachs_Gr shows the price for Halozyme Therapeutics Inc. has slightly increased by 9.73%. This prediction currently runs until 04.12.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Halozyme Therapeutics Inc. | 1.798% | 1.798% |
| iShares Core DAX® | 3.593% | 3.931% |
| iShares Nasdaq 100 | 5.810% | 5.518% |
| iShares Nikkei 225® | 4.075% | 8.460% |
| iShares S&P 500 | 4.142% | 4.039% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Halozyme Therapeutics Inc. diskutieren
Halozyme Therapeutics (NASDAQ:HALO) had its "sell" rating reaffirmed by analysts at The Goldman Sachs Group, Inc.. They now have a $56.00 price target on the stock.
Ratings data for HALO provided by MarketBeat